Identification of biomarker in patients on high dose warfarin : an iTRAQ-coupled LC-MS/MS approach
Warfarin is a widely prescribed anticoagulant for the treatment and prevention of thrombotic diseases. Warfarin has a narrow therapeutic range and a given dose has more than 10-fold inter-individual variability in its pharmacodynamic effects. An insufficient dose may fail to prevent thromboembolism...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
2009
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/16452 |